Lutikizumab Biosimilar Bispecific Dual-Variable-Domain Antibody (IL-1α × IL-1β) for Research

Cat No.: GMP-Bios-ab-331

Pre-Made Lutikizumab biosimilar, Bispecific Dual Variable Domain IG, Anti-IL1A;IL1B Antibody: Anti-IL1/IL-1A/IL1F1/IL1-ALPHA/IL-1 alpha;IL-1/IL1-BETA/IL1F2/IL1beta therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.



Order Information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. →
Catalog No. Package Price(In USD)
GMP-Bios-ab-331-1mg 1mg
GMP-Bios-ab-331-10mg 10mg
GMP-Bios-ab-331-100mg 100mg
GMP-Bios-ab-331-xmg ≥100mg



Product Details

Products Name (INN Index) Pre-Made Lutikizumab biosimilar, Bispecific Dual Variable Domain IG, Anti-IL1A;IL1B Antibody: Anti-IL1/IL-1A/IL1F1/IL1-ALPHA/IL-1 alpha;IL-1/IL1-BETA/IL1F2/IL1beta therapeutic antibody
INN Name Lutikizumab
TargetIL1A;IL1B
FormatBispecific Dual Variable Domain IG
DerivationBispecific antibody
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa;Kappa
Highest_Clin_Trial (Jan '20)Phase-II
Est. StatusDiscontinued
100% SI StructureNone;None
99% SI StructureNone;None
95-98% SI StructureNone;None
Year Proposed2016
Year Recommended2017
CompaniesAbbott Laboratories;AbbVie
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedOsteoarthritis
Development TechDual Variable Domain Immunoglobulin Technology



About target - IL1A

1. Protein Interleukin-1 alpha

2. Gene IL1A

3. Organism Homo sapiens (Human)

Function
Produced by activated macrophages, IL-1 stimulates thymocyte proliferation by inducing IL-2 release, B-cell maturation and proliferation, and fibroblast growth factor activity. IL-1 proteins are involved in the inflammatory response, being identified as endogenous pyrogens, and are reported to stimulate the release of prostaglandin and collagenase from synovial cells.